Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update

Go back to Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update

Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 1c

August 10, 2020 4:30 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q2 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $29.6 million versus the consensus estimate of $29.48 million.

Despite operating under COVID-19 conditions, I am quite pleased with the resiliency of our team... More